Bayer Pharmaceutical Gets CDSCO Panel Nod To Import And Market Octocog alfa for hemophilia A Dr. Divya Colin2 April 2025 6:00 PM ISTNew Delhi: Granting the phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
FDA Approves fitusiran for Hemophilia A and B Dr. Kamal Kant Kohli2 April 2025 9:15 AM ISTThe FDA has approved fitusiran, now named Qfitlia, for routine prophylaxis in patients aged 12 and older with hemophilia A or B, with or without...
USFDA approves Sanofi Qfitlia for hemophilia A or B with or without inhibitors Ruchika Sharma29 March 2025 11:30 AM ISTParis: Sanofi has announced that the Company has received approval from the US Food and Drug Administration (FDA) for Qfitlia...
Novo Nordisk Gets CDSCO Panel Nod To Import, Market Concizumab Injection Dr. Divya Colin5 March 2025 6:00 PM ISTNew Delhi: Citing that there is unmet medical need in the country for the proposed indication, the Subject Expert Committee (SEC) functional under the...
Medical Bulletin 18/ January/ 2025 Dr. Bhumika Maikhuri18 Jan 2025 3:00 PM ISTHere are the top medical news for the day:New AI Model Detects Early Signs of Cognitive Decline in Menopausal Women: Study FindsA new study suggests...
New Study Reveals How Saliva Activates Coagulation in Hemophilia A Patients Dr. Bhumika Maikhuri18 Jan 2025 8:30 AM ISTA recent study provides insights into the mechanisms of coagulation in persons with haemophilia A. The research team was able to show that saliva...
Pfizer ceases development of Hemophilia A gene therapy Giroctocogene Fitelparvovec Ruchika Sharma31 Dec 2024 10:00 AM ISTRichmond: Sangamo Therapeutics, Inc., a genomic medicine company, has announced it will regain development and commercialization rights to...
Novo Nordisk bleeding disorder injection gets USFDA nod Ruchika Sharma21 Dec 2024 11:30 AM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Alhemo (concizumab-mtci) injection as a...
FDA Approves New treatment option for cutting bleeding in Hemophilia A or B Dr. Kamal Kant Kohli12 Oct 2024 11:00 AM ISTHemophilia A and hemophilia B are genetic bleeding disorders caused by a dysfunction or deficiency of coagulation factor VIII (FVIII) or IX (FIX),...
Weekly Efanesoctocog Alfa effective option for Preventing Bleeding among kids with Severe Hemophilia A: NEJM Nidhi Srivastava11 Aug 2024 9:00 PM ISTMilan: An article published in The New England Journal of Medicine revealed that in children with severe hemophilia A, once-weekly prophylaxis with...
Prophylactic Efmoroctocog Alfa may improve outcomes in patients with hemophilia A: Study Jacinthlyn Sylvia13 March 2024 9:00 PM ISTA recent retrospective study published in the journal of Hematology explored the clinical characteristics and treatment patterns of patients...
Pfizer Marstacimab regulatory submissions for treatment of Hemophilia A and B accepted by USFDA, EMA Ruchika Sharma12 Dec 2023 11:28 AM ISTThe submissions for marstacimab are based on efficacy and safety data from the Phase 3 BASIS trial.
